Literature DB >> 4830496

Effect of levamisole (NSC-177023) on in vitro human lymphocyte transformation.

D Copeland, T Stewart, J Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4830496

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  8 in total

1.  Augmentation of the in vitro mitogenic response of owl monkey peripheral blood lymphocytes by levamisole and loss of this effect with the development of herpesvirus saimiri-induced lymphoma.

Authors:  R H Neubauer; H Rabin
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

2.  The in vitro evaluation of certain neutrophil and lymphocyte functions following the ingestion of 150 mg oral dose of levamisole: assessment of the extent and duration of stimulation of neutrophil chemotaxis, protein iodination and lymphocyte transformation.

Authors:  R Anderson; R Oosthuizen; A Theron; A J Van Rensburg
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

3.  L-tetramisole. Enhancement of human lymphocyte response to antigen.

Authors:  H F Pabst; J Crawford
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

4.  Human monocyte-lymphocyte interaction and its enhancement by levamisole.

Authors:  J W Kazura; W Negendank; D Guerry; A D Schreiber
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

5.  Effect of levamisole on Mycobacterium leprae in mice.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

6.  In vitro reversal of cellular unresponsiveness induced by levamisole.

Authors:  H Golding; B Golding; R Jacobson; R Lomnitzer; H J Koornhof; A R Rabson
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

7.  Effect of levamisole and azathioprine on the human mixed lymphocyte reaction (MLR).

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

8.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.